EA202091881A1 - Соединения для лечения боли - Google Patents

Соединения для лечения боли

Info

Publication number
EA202091881A1
EA202091881A1 EA202091881A EA202091881A EA202091881A1 EA 202091881 A1 EA202091881 A1 EA 202091881A1 EA 202091881 A EA202091881 A EA 202091881A EA 202091881 A EA202091881 A EA 202091881A EA 202091881 A1 EA202091881 A1 EA 202091881A1
Authority
EA
Eurasian Patent Office
Prior art keywords
compounds
pain treatment
pain
treatment
useful
Prior art date
Application number
EA202091881A
Other languages
English (en)
Inventor
Томас Уинн
Хуан Альварес
Деметри Мустакас
Маркус Хеберлейн
Льюис Пеннингтон
Original Assignee
Алкермес, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Алкермес, Инк. filed Critical Алкермес, Инк.
Publication of EA202091881A1 publication Critical patent/EA202091881A1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22—Bridged ring systems
    • C07D221/26—Benzomorphans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

В настоящем документе предложены соединения, которые полезны при лечении боли у субъекта.
EA202091881A 2018-02-05 2019-02-04 Соединения для лечения боли EA202091881A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862626499P 2018-02-05 2018-02-05
PCT/US2019/016543 WO2019152946A1 (en) 2018-02-05 2019-02-04 Compounds for the treatment of pain

Publications (1)

Publication Number Publication Date
EA202091881A1 true EA202091881A1 (ru) 2020-11-10

Family

ID=65444375

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202091881A EA202091881A1 (ru) 2018-02-05 2019-02-04 Соединения для лечения боли

Country Status (14)

Country Link
US (3) US10604489B2 (ru)
EP (1) EP3749667A1 (ru)
JP (1) JP2021512952A (ru)
KR (1) KR20200136384A (ru)
CN (1) CN111989327A (ru)
AU (1) AU2019216522A1 (ru)
BR (1) BR112020015712A2 (ru)
CA (1) CA3090385A1 (ru)
EA (1) EA202091881A1 (ru)
IL (1) IL276482A (ru)
MA (1) MA51738A (ru)
MX (1) MX2020008195A (ru)
SG (1) SG11202007422QA (ru)
WO (1) WO2019152946A1 (ru)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20200136384A (ko) * 2018-02-05 2020-12-07 알케르메스, 인코포레이티드 통증 치료용 화합물
WO2021026377A1 (en) * 2019-08-07 2021-02-11 Alkermes, Inc. Lactam-containing compounds for the treatment of pain
WO2021026380A1 (en) * 2019-08-07 2021-02-11 Alkermes, Inc. Phenyltriazole compounds for the treatment of pain
WO2021026375A1 (en) * 2019-08-07 2021-02-11 Alkermes, Inc. Fused bicyclic compounds for the treatment of pain
WO2021026378A1 (en) * 2019-08-07 2021-02-11 Alkermes, Inc. Indole compounds for the treatment of pain
TW202142537A (zh) 2020-02-04 2021-11-16 美商艾爾凱默斯公司 ３－（（１Ｒ，５Ｓ，９ｒ）－９－乙氧基－３－氮雜雙環并［３．３．１］壬烷－９－基）—苯甲醯胺之結晶形式及其鹽形式

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3167562A (en) 1965-01-26 New j-azabicyclo
GB952137A (en) 1961-03-14 1964-03-11 Sankyo Co New 3-azabicyclo [3.3.1] nonane compounds and a process for preparing these compounds
US3196154A (en) 1962-05-17 1965-07-20 Sterling Drug Inc 3-substituted-9-methyl-3, 9-diazabicyclo [3.3.1] nonanes
US3475439A (en) 1966-05-07 1969-10-28 Sankyo Co 3-azabicyclo(3.3.1)nonane compounds
GB1195746A (en) 1967-06-07 1970-06-24 Yoshitomi Pharmaceutical 3-Azabicyclo [3,3,1] Nonane Derivatives
GB1393253A (en) 1971-09-10 1975-05-07 Wyeth John & Brother Ltd 3-azabicyclo-3,3,1-nonanes
JPS4856680A (ru) 1971-11-18 1973-08-09
JPS4961168A (ru) 1972-10-14 1974-06-13
IL59004A0 (en) * 1978-12-30 1980-03-31 Beecham Group Ltd Substituted benzamides their preparation and pharmaceutical compositions containing them
JPS5592384A (en) * 1978-12-30 1980-07-12 Beecham Group Ltd Compound having pharmacological activity
CA2064853C (en) 1990-06-05 1999-08-24 Hiroshi Nagase Indole derivatives
EP0483403A1 (en) 1990-10-31 1992-05-06 Hoechst Aktiengesellschaft Derivatives of amino acids as inhibitors of renin, methods for their preparation, medicaments containing them and their use
DE4341403A1 (de) 1993-12-04 1995-06-08 Basf Ag N-substituierte 3-Azabicycloalkan-Derivate, ihre Herstellung und Verwendung
US5541217A (en) 1995-05-17 1996-07-30 Ortho Pharmaceutical Corporation 4-arylcyclopenta[c]pyrrole analgesics
JP2808089B2 (ja) 1995-08-29 1998-10-08 レーザーテクノ株式会社 墨出し用レーザー装置
TWI244481B (en) 1998-12-23 2005-12-01 Pfizer 3-azabicyclo[3.1.0]hexane derivatives useful in therapy
DE19952146A1 (de) 1999-10-29 2001-06-07 Boehringer Ingelheim Pharma Arylalkane, Arylalkene und Aryl-azaalkane, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
US6852716B2 (en) * 2002-02-15 2005-02-08 Pfizer Inc Substituted-aryl compounds for treatment of disease
US7056930B2 (en) 2003-04-14 2006-06-06 Pfizer Inc. 2-Azabicyclo[3.3.1]nonane derivatives
BRPI0409307A (pt) * 2003-04-14 2006-04-25 Pfizer Prod Inc derivados de 3-azabiciclo[3.2.1]octano
US20050043327A1 (en) * 2003-08-21 2005-02-24 Pfizer Inc Pharmaceutical composition for the prevention and treatment of addiction in a mammal
AU2004282201A1 (en) 2003-10-15 2005-04-28 Targacept, Inc. Azabicycyclic compounds for relieving pain and treating central nervous system disorders
WO2006002133A1 (en) 2004-06-22 2006-01-05 Schering Corporation Cannabinoid receptor ligands
WO2007029156A2 (en) 2005-09-05 2007-03-15 Ranbaxy Laboratories Limited Isoindoledione derivatives as adrenergic receptor antagonists
US7538110B2 (en) 2005-10-27 2009-05-26 Adolor Corporation Opioid antagonists
MX2008005792A (es) 2005-11-03 2008-10-21 Activbiotics Pharma Llc Analogos de rifamicina y usos de ella.
MY145633A (en) 2006-03-01 2012-03-15 Theravance Inc 8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
FR2918986B1 (fr) 2007-07-19 2009-09-04 Sanofi Aventis Sa Derives de 6-cycloamino-3-(pyridazin-4-yl)imidazo[1,2-b]- pyridazine, leur preparation et leur application en therapeutique
TWI423801B (zh) 2007-08-27 2014-01-21 Theravance Inc 作為μ類鴉片受體拮抗劑之８－氮雜雙環〔３．２．１〕辛基－２－羥基苯甲醯胺化合物
US8048895B2 (en) 2008-04-18 2011-11-01 Research Triangle Institute Kappa opioid receptor ligands
GB0815947D0 (en) 2008-09-02 2008-10-08 Univ Dundee Compounds
US8759357B2 (en) 2009-10-08 2014-06-24 Merck Sharp & Dohme Corp. Inhibitors of fatty acid binding protein (FABP)
FR2953839A1 (fr) 2009-12-14 2011-06-17 Sanofi Aventis Nouveaux derives d'(heterocycle-piperidine condensee)-(piperazinyl)-1alcanone ou d'(heterocycle-pyrrolidine condensee)-(piperazinyl)-1alcanone et leur utilisation comme inhibiteurs de p75
TW201209054A (en) 2010-05-28 2012-03-01 Prosidion Ltd Novel compounds
US8354420B2 (en) 2010-06-04 2013-01-15 Genentech, Inc. Aminopyrimidine derivatives as LRRK2 inhibitors
WO2012075232A1 (en) 2010-12-04 2012-06-07 Trevena, Inc. Opioid receptor ligands and methods of using and making the same
ES2857549T3 (es) 2011-03-23 2021-09-29 Trevena Inc Ligandos de receptores de opioides y métodos para utilizar y obtener los mismos
JP2014237589A (ja) 2011-09-28 2014-12-18 日本曹達株式会社 環状アミン化合物および有害生物防除剤
GB2498976A (en) 2012-02-01 2013-08-07 Prosidion Ltd GPR119 agonists useful in the treatment of type II diabetes
JP2015083543A (ja) 2012-02-14 2015-04-30 大日本住友製薬株式会社 新規縮環ピロリジン誘導体
PL2716291T3 (pl) * 2012-10-08 2020-06-15 Universität Ulm Połączenie opioidów i leków przeciwnowotworowych do leczenia nowotworów
WO2014194519A1 (en) 2013-06-07 2014-12-11 Merck Sharp & Dohme Corp. Imidazole derivatives and methods of use thereof for improving pharmacokinetics of drug
WO2015091931A1 (en) 2013-12-20 2015-06-25 AbbVie Deutschland GmbH & Co. KG Oxindole derivatives carrying a piperidyl-substituted azetidinyl substituent and use thereof for treating vasopressine-related diseases
NO2721710T3 (ru) 2014-08-21 2018-03-31
SG11201901452UA (en) 2016-09-01 2019-03-28 Mebias Discovery Llc Substituted ureas and methods of making and using same
CA3050515A1 (en) 2017-01-17 2018-07-26 Mebias Discovery, Inc. Substituted 3-dialkylaminomethyl-piperidin-4-yl-benzamides and methods of making and using same
KR20200136384A (ko) * 2018-02-05 2020-12-07 알케르메스, 인코포레이티드 통증 치료용 화합물

Also Published As

Publication number Publication date
US20190241524A1 (en) 2019-08-08
EP3749667A1 (en) 2020-12-16
CN111989327A (zh) 2020-11-24
US20200255383A1 (en) 2020-08-13
IL276482A (en) 2020-09-30
MX2020008195A (es) 2020-11-24
CA3090385A1 (en) 2019-08-08
BR112020015712A2 (pt) 2020-12-08
KR20200136384A (ko) 2020-12-07
MA51738A (fr) 2021-05-12
AU2019216522A1 (en) 2020-08-27
JP2021512952A (ja) 2021-05-20
WO2019152946A1 (en) 2019-08-08
US11180455B2 (en) 2021-11-23
SG11202007422QA (en) 2020-09-29
US10604489B2 (en) 2020-03-31
US20220033394A1 (en) 2022-02-03

Similar Documents

Publication Publication Date Title
EA202091881A1 (ru) Соединения для лечения боли
CA193736S (en) Skin massager
EA201992497A1 (ru) МОДУЛЯТОРЫ K-Ras
MX2019007030A (es) Composiciones y metodos para el tratamiento del cancer.
MD3209310T2 (ro) Compoziții care conțin tulpini bacteriene
CL2020000173S1 (es) Masajeador.
MD3209381T2 (ro) Compoziții care conțin tulpini bacteriene
EA201991818A1 (ru) Лечение рака
GB2541571A (en) Pharmaceutical compositions
EA201792443A1 (ru) МОДУЛЯТОРЫ K-Ras
EA201891340A1 (ru) Лечение рака с использованием 2-дезокси-2-фтор-l-фукозы в комбинации с ингибитором контрольных точек
EA201990296A1 (ru) Антитела против siglec-7 для лечения рака
UY37834A (es) Tratamiento de mh con compuestos de pirimidinadiona
BR112016018170A2 (pt) métodos para tratar doença de alzheimer
EA201692472A1 (ru) Соединения для лечения рака мозга
DK3784103T3 (da) Gulvbehandlingsmaskine
EA202191086A1 (ru) Комбинированная терапия меланомы
EA201790312A1 (ru) Комбинации лекарственных средств для лечения множественной миеломы
TN2019000210A1 (en) Antitumoral compounds
EA201692534A1 (ru) Способы лечения гипотонии
TR201905392T4 (tr) Ağrı tedavisi.
MX2017016114A (es) Metodos para tratar o prevenir una proteopatia.
MX2018005987A (es) Compuestos heterociclicos para el tratamiento de enfermedades.
EA202092824A1 (ru) Комбинированная терапия
EA201690446A1 (ru) Лечение множественной миеломы